Neurocrine Biosciences, Inc. (NBIX)

Healthcare · Drug Manufacturers Specialty Generic · NASDAQ

Neurocrine Biosciences, Inc. (NBIX) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $14.46B, a trailing price-to-earnings ratio of 16.1 and a free-cash-flow yield of 5.1%. Over the most recent reported fiscal year, revenue grew 21.4% and free cash flow per share grew 35.9%.

Market cap	$14.46B
Trailing P/E	16.1
FCF yield	5.1%
Revenue growth (YoY)	+21.4%
EPS growth (YoY)	+1.1%
FCF/share growth (YoY)	+35.9%
Exchange	NASDAQ
Sector	Healthcare
Industry	Drug Manufacturers Specialty Generic

Explore live NBIX data on Nama Insights →

Recent Congressional trades

Neurocrine Biosciences, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Lisa McClain	House	Sell	$1,001 - $15,000	Aug 13, 2025
Lisa McClain	House	Buy	$1,001 - $15,000	Aug 13, 2025